Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with psoriasis or psoriatic arthritis. Patients who routinely see dermatologists or rheumatologists for psoriasis or psoriatic...
Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with psoriasis or psoriatic arthritis. Patients who routinely see dermatologists or rheumatologists for psoriasis or psoriatic...
Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with psoriasis or psoriatic arthritis.
TUESDAY, June 17, 2025 (HealthDay News) -- The PanDerm artificial intelligence (AI) model improves skin cancer diagnosis when used by doctors, according to a research article published online June 6 in Nature Medicine.Siyuan Yan, from Monash University in...
Soumya Chakravarty, MD, PhD, FACP, FACR, senior director, strategic lead rheumatology therapeutic area, Johnson & Johnson Innovative Medicine, highlights the APEX study's findings that Tremfya (guselkumab) is the first IL-23 inhibitor to significantly inhibit structural damage progression in biologic-naïve psoriatic arthritis patients, offering a multi-domain, early treatment option with a consistent safety profile to help preserve long-term function and quality of life.
The following is a summary of “Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicenter study,” published in the June 2025 issue of Rheumatology by Azuaga et al.
The following is a summary of “Patient Satisfaction Following Phlebectomy for Prominent Temporal and Periorbital Facial Veins—Results From Our First Cohort of Patients,” published in the June 2025 issue of Journal of Cosmetic Dermatology by Muschamp et al.
Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with psoriasis or psoriatic arthritis.
TUESDAY, June 17, 2025 (HealthDay News) -- The PanDerm artificial intelligence (AI) model improves skin cancer diagnosis when used by doctors, according to a research article published online June 6 in Nature Medicine.Siyuan Yan, from Monash University in...
Soumya Chakravarty, MD, PhD, FACP, FACR, senior director, strategic lead rheumatology therapeutic area, Johnson & Johnson Innovative Medicine, highlights the APEX study's findings that Tremfya (guselkumab) is the first IL-23 inhibitor to significantly inhibit structural damage progression in biologic-naïve psoriatic arthritis patients, offering a multi-domain, early treatment option with a consistent safety profile to help preserve long-term function and quality of life.
The following is a summary of “Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicenter study,” published in the June 2025 issue of Rheumatology by Azuaga et al.
The following is a summary of “Patient Satisfaction Following Phlebectomy for Prominent Temporal and Periorbital Facial Veins—Results From Our First Cohort of Patients,” published in the June 2025 issue of Journal of Cosmetic Dermatology by Muschamp et al.
You ask, she answers! Dr. MedLaw responds to a physician’s question regarding fee-splitting, leading to a discussion of kickbacks and regulatory claims. Physican: I’m expanding my internal medicine practice to include more wellness care, and I want to market that....
Dr. Alex McDonald shares a letter he recently sent to Senator Bill Cassidy expressing urgent concerns regarding HHS leadership and public health integrity. Dear Senator Cassidy, As a family and sports medicine physician and a concerned citizen, I am writing to you...
You ask, she answers! Dr. MedLaw responds to a physician's question regarding how to decrease liability risk for on-call telephone consultations.
This course discusses a study that examined the prognostic role of tumor budding in cutaneous squamous cell carcinoma.
This course discusses a literature review that provided updates and challenges related to AI and dermatological care for patients with skin of color.
This course discusses a review that provides guidance for cardiovascular disease screening type and frequency in patients with psoriasis.
Paging laughter: this week’s medical cartoon delivers an infusion of healthcare humor, zero adverse events, and rapid onset of...
Here’s your weekly medical cartoon—a quick dose of humor and insight to brighten your day and reflect the quirks of life in...
Physicians can secure a steady, tax-advantaged retirement income through options like lifetime annuities and QLACs, tailored to their needs and timelines. Preparing for retirement can be daunting for many people, and physicians are no exception. Identifying the...
Physicians should explore retirement planning options and employ a strategy that limits volatility, guards against outliving assets, and preserves buying power.
Generational conflicts in the medical workplace can cause problems, but fostering open dialogue and building inclusivity can improve collaboration and trust.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.